Terns Pharma Q1 EPS $(0.26) Beats $(0.28) Estimate

Benzinga · 05/08 21:02
Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 13.33 percent increase over losses of $(0.30) per share from the same period last year.